Chongqing Xishan Science&Technology Co. Ltd. A
Chongqing Xishan Science & Technology Co., Ltd. engages in the research and development, manufacturing, sale, and service of digital minimally invasive surgical equipment and medical consumables in China and internationally. The company offers powered surgical instruments, such as micromotor, handpiece, attachment, shaver, bur, saw blade, and perforator; vacuum-assisted breast biopsy, including c… Read more
Chongqing Xishan Science&Technology Co. Ltd. A (688576) - Total Assets
Latest total assets as of June 2025: CN¥1.85 Billion CNY
Based on the latest financial reports, Chongqing Xishan Science&Technology Co. Ltd. A (688576) holds total assets worth CN¥1.85 Billion CNY as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Chongqing Xishan Science&Technology Co. Ltd. A - Total Assets Trend (2021–2024)
This chart illustrates how Chongqing Xishan Science&Technology Co. Ltd. A’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Chongqing Xishan Science&Technology Co. Ltd. A - Asset Composition Analysis
Current Asset Composition (December 2024)
Chongqing Xishan Science&Technology Co. Ltd. A's total assets of CN¥1.85 Billion consist of 60.0% current assets and 40.0% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 29.0% |
| Accounts Receivable | CN¥74.15 Million | 3.9% |
| Inventory | CN¥75.33 Million | 3.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥22.32 Million | 1.2% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how Chongqing Xishan Science&Technology Co. Ltd. A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Chongqing Xishan Science&Technology Co. Ltd. A's current assets represent 60.0% of total assets in 2024, a decrease from 90.4% in 2021.
- Cash Position: Cash and equivalents constituted 29.0% of total assets in 2024, down from 75.4% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2021.
- Asset Diversification: The largest asset category is inventory at 3.9% of total assets.
Chongqing Xishan Science&Technology Co. Ltd. A Competitors by Total Assets
Key competitors of Chongqing Xishan Science&Technology Co. Ltd. A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
Chongqing Xishan Science&Technology Co. Ltd. A - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Chongqing Xishan Science&Technology Co. Ltd. A generates 0.17x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Chongqing Xishan Science&Technology Co. Ltd. A generates $5.12 in net profit.
Chongqing Xishan Science&Technology Co. Ltd. A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 7.74 | 10.10 | 10.10 |
| Quick Ratio | 7.13 | 9.63 | 9.63 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥904.32 Million | CN¥ 1.42 Billion | CN¥ 1.42 Billion |
Chongqing Xishan Science&Technology Co. Ltd. A - Advanced Valuation Insights
This section examines the relationship between Chongqing Xishan Science&Technology Co. Ltd. A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.05 |
| Latest Market Cap to Assets Ratio | 0.11 |
| Asset Growth Rate (YoY) | -16.9% |
| Total Assets | CN¥1.93 Billion |
| Market Capitalization | $217.07 Million USD |
Valuation Analysis
Below Book Valuation: The market values Chongqing Xishan Science&Technology Co. Ltd. A's assets below their book value (0.11 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Chongqing Xishan Science&Technology Co. Ltd. A's assets decreased by 16.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Chongqing Xishan Science&Technology Co. Ltd. A (2021–2024)
The table below shows the annual total assets of Chongqing Xishan Science&Technology Co. Ltd. A from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.93 Billion | -16.92% |
| 2023-12-31 | CN¥2.32 Billion | +343.51% |
| 2022-12-31 | CN¥522.66 Million | +29.51% |
| 2021-12-31 | CN¥403.58 Million | -- |